Joel Beatty
Stock Analyst at Baird
(4.62)
# 221
Out of 5,182 analysts
212
Total ratings
52.66%
Success rate
36.18%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Outperform | $32 → $34 | $19.45 | +74.81% | 4 | Apr 7, 2026 | |
| IMMP Immutep | Downgrades: Neutral | $7 → $1 | $0.57 | +75.16% | 6 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $89.82 | +46.96% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $12.42 | +61.03% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $329.60 | +31.37% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $24.28 | +93.57% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $199.96 | +4.52% | 5 | Nov 18, 2025 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $145 → $125 | $66.23 | +88.74% | 9 | Nov 6, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $17.32 | +9.70% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $4.50 | +55.56% | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $6 | $3.21 | +86.92% | 5 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $36.14 | -75.10% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $22.11 | +40.21% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $26.95 | -10.95% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $787.95 | -13.70% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $68.59 | -3.78% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $182.72 | -11.34% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $33.91 | +20.91% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $27.68 | +15.61% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $88.68 | -15.43% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $53.98 | +20.41% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.22 | +108,990.91% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.50 | +200.00% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $16.57 | +50.88% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $21.00 | +33.33% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.38 | +1,059.42% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.66 | -24.70% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.26 | +3,392.06% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $74.40 | -22.04% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $30.70 | -21.82% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $8.47 | +112.51% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.67 | +259.28% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $10.35 | +170.53% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $313.79 | -44.23% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $6.69 | +109.27% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $20.42 | +428.89% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $74.09 | +5.28% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $19.34 | +417.06% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $14.59 | +722.48% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $4.28 | +10,414.02% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.91 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $8.15 | +84.05% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $16.34 | -35.74% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $9.27 | +104.96% | 3 | Nov 10, 2017 |
Denali Therapeutics
Apr 7, 2026
Maintains: Outperform
Price Target: $32 → $34
Current: $19.45
Upside: +74.81%
Immutep
Mar 13, 2026
Downgrades: Neutral
Price Target: $7 → $1
Current: $0.57
Upside: +75.16%
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $89.82
Upside: +46.96%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $12.42
Upside: +61.03%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $329.60
Upside: +31.37%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $24.28
Upside: +93.57%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $199.96
Upside: +4.52%
e.l.f. Beauty
Nov 6, 2025
Maintains: Outperform
Price Target: $145 → $125
Current: $66.23
Upside: +88.74%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $17.32
Upside: +9.70%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $4.50
Upside: +55.56%
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $3.21
Upside: +86.92%
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $36.14
Upside: -75.10%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.11
Upside: +40.21%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $26.95
Upside: -10.95%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $787.95
Upside: -13.70%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $68.59
Upside: -3.78%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $182.72
Upside: -11.34%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $33.91
Upside: +20.91%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $27.68
Upside: +15.61%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $88.68
Upside: -15.43%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $53.98
Upside: +20.41%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.22
Upside: +108,990.91%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.50
Upside: +200.00%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $16.57
Upside: +50.88%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $21.00
Upside: +33.33%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.38
Upside: +1,059.42%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.66
Upside: -24.70%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.26
Upside: +3,392.06%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $74.40
Upside: -22.04%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $30.70
Upside: -21.82%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $8.47
Upside: +112.51%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.67
Upside: +259.28%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $10.35
Upside: +170.53%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $313.79
Upside: -44.23%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $6.69
Upside: +109.27%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $20.42
Upside: +428.89%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $74.09
Upside: +5.28%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $19.34
Upside: +417.06%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $14.59
Upside: +722.48%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $4.28
Upside: +10,414.02%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $1.91
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $8.15
Upside: +84.05%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $16.34
Upside: -35.74%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $9.27
Upside: +104.96%